Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Since the first-in-human procedure in 2002, transcatheter aortic valve implantation (TAVI)
has become a well-established therapeutic option for severe aortic stenosis, and is offered …

Importance The frequency and clinical importance of structural valve deterioration (SVD) in
patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) or surgery …

Abstract Background and Aims Transcatheter aortic valve implantation (TAVI) has become a
viable treatment option for patients with severe aortic valve stenosis across a broad range of …

Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Introduction Since 2007, transcatheter aortic valve implantation (TAVI) has emerged as
another treatment strategy for severe symptomatic aortic stenosis (AS) compared with …

BACKGROUND: Elevated aortic valve gradients are common after transcatheter aortic valve
implantation for degenerated surgical aortic valve replacement bioprostheses, but their …

Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an
effective treatment for patients with symptomatically failing bioprosthetic valves and a high …

Background Coronary obstruction and access are concerns in patients undergoing redo
transcatheter aortic valve implantation (TAVI). Aims We sought to assess the neoskirt height …

Background Coronary access after transcatheter aortic valve implantation (TAVI) with supra-
annular self-expandable valves may be challenging or un-feasible. There is little data …